ab 14 August 2024 Global Research and Evidence Lab Acumen Pharmaceuticals Inc to $6 on lowered sabirnetug estimates amid class setbacks, remains Buy Thoughts post 2Q24 & a thesis revisit: cutting PT P2 execution is now a key thesis, lowering PT along with volatile market We updated our model post 2Q EPS, including a reevaluation of the launch trajectory and market potential for sabirnetug (ACU193). We continue to expect a potential launch in 2H28 on the stand-alone P2 ALTITUDE-AD study results (which we exp ...

ab 14 August 2024 Global Research and Evidence Lab First Read Payments, Processors, & FinTech NFC Secure Element within their own apps Apple announces broader developer access to Equities Americas Diversified Technology Services Timothy E. Chiodo, CFA Analyst timothy.chiodo@ubs.com +1-415-352 4500 Nik Cremo Analyst nik.cremo@ubs.com +1-415-352 6025 Chris Zhang, CFA Analyst chris.zhang@ubs.com +1-212-713 4911 Dylan Wright Analyst dylan.wright@ubs.com +1-212-713 3269 Jing Zhang Associate Analyst jing.zhang1@u ...

First Read US Weekly RevPAR Update Slightly Better RevPAR This Week Driven by Business Travel Weekly RevPAR up +2% YOY US Weekly RevPAR was up +2% YOY for August 4 - August 10 week, above last week's up +1%, with ADR up +140bps and occupancy up +40bps. ADR up +140bps was above last week's +60bps. Occupancy of up +40bps was slightly below last week's +50bps. RevPAR was up +11% vs. '19 per our calculations, broadly in line with last week's +11.5%. We estimate that ADR was up +20% vs. '19 (last week up +20%) a ...

ab 14 August 2024 Global Research and Evidence Lab Cruise Lines Rehash - August 14, 2024 Equities Americas Leisure Goods & Services Robin M. Farley Analyst robin.farley@ubs.com +1-212-713 2060 Arpine Kocharyan Analyst arpine.kocharyan@ubs.com +1-212-713 2086 Alex Kivali Associate Analyst alex.kivali@ubs.com +1-212-713 3945 Alexia Tsimikas Associate Analyst alexia.tsimikas@ubs.com +1-212-713 2183 See here and here for past rehashes. This report has been prepared by UBS Securities LLC. ANALYST CERTIFICATION A ...

ab 14 August 2024 Global Research and Evidence Lab Powered by YES UBS Evidence Lab July Web Traffic Data Equities Americas Internet Services 12-month rating Neutral * 12m price target US$11.00 Price (14 Aug 2024) US$9.36 RIC: UPWK.O BBG: UPWK US Trading data and key metrics | --- | --- | |-----------------------------|---------------| | 52-wk range | US$15.66-9.01 | | Market cap. | US$1.25b | | Shares o/s | 133m (COM) | | Free float | 87% | | Avg. daily volume ('000) | 2,156 | | Avg. daily value (m) | US$23 ...

Global Research and Evidence Lab 14 August 2024 Dayforce Inc. 2024 Boost amid $500m New Buyback = Buy Non-deal road show offers a glimpse at a Special Software Story We recently hosted Dayforce CEO David Ossip, CFO Jeremy Johnson as well as multiple members from investor relations. We continue to have substantial confidence in our thesis as we believe DAY stock is poised to outperform on cloud revenue remix + improving free cash flow conversion—we believe recent underperformance is mostly due to risk-off se ...

Global Research and Evidence Lab 14 August 2024 Fiverr International Ltd July Web Traffic Data Remains Soft Updated Stock Thoughts According to the UBS Evidence Lab Web Traffic Monitor ( > Access Dataset), monthly unique visitors to Fiverr.com slowed to -17% yoy in July from -15% in June. This marked the second consecutive month of worsening trends after web traffic comps have generally been improving since late 2023. Consensus for Q3 calls for a slight deceleration in GMV growth. While some deceleration is ...

Global Research and Evidence Lab 14 August 2024 LatAm Transport and Capital Goods Daily Take-Off: ERJ, TUPY, AZUL, COPA, RAIL ERJ: LATAM discussing up to 30 E2 Jets According to Aeroin, the Minister of Ports and Airports, Mr. Silvio Costa Filho, pointed out that LATAM is in negotiations to acquire jets from the Brazilian manufacturer. Moreover, the article states that LATAM expects to grow more than 10% in the next three years and is considering buying 30 planes. Nonetheless, the CEO of LATAM Brazil, Mr. Je ...

Global Research and Evidence Lab 14 August 2024 lbotta Inc 2Q24 EPS Recap - Clean up on aisle two Key Takeaways The silver lining here is the Instacart partnership (we est'ed ~6% upside to our FY25 rev ests from CART here) should catalyze other potential 3P partners to work with IBTA as well as new brands. And in a nutshell, more/better 3P retail partnerships is why we've been constructive on IBTA from the start. So while softer ad revenue limits upside to our headline FY25 rev/EBITDA ests, looking further ...

Global Research and Evidence Lab 14 August 2024 Equities Americas Healthcare Kevin Caliendo Analyst kevin.caliendo@ubs.com +1-212-713 3630 AJ Rice Analyst aj.rice@ubs.com. +1-212-713 4299 Christopher Mercado, CFA Associate Analyst christopher.mercado@ubs.com +1-212-713 1430 Andrea Alfonso Analyst andrea.alfonso@ubs.com +1-212-713 1342 Dylan Finley Associate Analyst dylan.finley@ubs.com +1-212-713-4880 US Healthcare A Look at Today's Stock Movers, News & Key Data What We Thought Was Interesting Today Today w ...